386 related articles for article (PubMed ID: 18533766)
41. Antipsychotics in children and adolescents.
Campbell M; Rapoport JL; Simpson GM
J Am Acad Child Adolesc Psychiatry; 1999 May; 38(5):537-45. PubMed ID: 10230185
[TBL] [Abstract][Full Text] [Related]
42. Prolactin elevation with antipsychotic medications: mechanisms of action and clinical consequences.
Maguire GA
J Clin Psychiatry; 2002; 63 Suppl 4():56-62. PubMed ID: 11913677
[TBL] [Abstract][Full Text] [Related]
43. Antipsychotic safety and efficacy concerns.
Meyer JM
J Clin Psychiatry; 2007; 68 Suppl 14():20-6. PubMed ID: 18284274
[TBL] [Abstract][Full Text] [Related]
44. Typical and atypical antipsychotics--the misleading dichotomy. Results from the Working Group 'Drugs in Psychiatry' (AGATE).
Fischer-Barnicol D; Lanquillon S; Haen E; Zofel P; Koch HJ; Dose M; Klein HE;
Neuropsychobiology; 2008; 57(1-2):80-7. PubMed ID: 18515977
[TBL] [Abstract][Full Text] [Related]
45. Pharmacologic management of psychosis in the elderly.
Sable JA; Jeste DV
J Nutr Health Aging; 2003; 7(6):421-7. PubMed ID: 14625622
[TBL] [Abstract][Full Text] [Related]
46. Cardiovascular effects of antipsychotics.
Michelsen JW; Meyer JM
Expert Rev Neurother; 2007 Jul; 7(7):829-39. PubMed ID: 17610390
[TBL] [Abstract][Full Text] [Related]
47. Reducing the burden of side effects during long-term antipsychotic therapy: the role of "switching" medications.
Weiden PJ; Buckley PF
J Clin Psychiatry; 2007; 68 Suppl 6():14-23. PubMed ID: 17650055
[TBL] [Abstract][Full Text] [Related]
48. Schizophrenia, obesity, and antipsychotic medications: what can we do?
Citrome L; Vreeland B
Postgrad Med; 2008 Jul; 120(2):18-33. PubMed ID: 18654065
[TBL] [Abstract][Full Text] [Related]
49. Review and management of clozapine side effects.
Miller DD
J Clin Psychiatry; 2000; 61 Suppl 8():14-7; discussion 18-9. PubMed ID: 10811238
[TBL] [Abstract][Full Text] [Related]
50. Antipsychotic drug toxicology in children.
Caccia S; Clavenna A; Bonati M
Expert Opin Drug Metab Toxicol; 2011 May; 7(5):591-608. PubMed ID: 21401439
[TBL] [Abstract][Full Text] [Related]
51. An overview of side effects caused by typical antipsychotics.
Arana GW
J Clin Psychiatry; 2000; 61 Suppl 8():5-11; discussion 12-3. PubMed ID: 10811237
[TBL] [Abstract][Full Text] [Related]
52. [Extrapyramidal effects of antipsychotic drugs].
Kulisevsky J; Otermin P
Neurologia; 2003 Jun; 18(5):262-8. PubMed ID: 12768512
[TBL] [Abstract][Full Text] [Related]
53. Safety issues with drug therapies for autism spectrum disorders.
McCracken JT
J Clin Psychiatry; 2005; 66 Suppl 10():32-7. PubMed ID: 16401148
[TBL] [Abstract][Full Text] [Related]
54. Medical risk in patients with bipolar disorder and schizophrenia.
Newcomer JW
J Clin Psychiatry; 2006 Nov; 67(11):e16. PubMed ID: 17201046
[TBL] [Abstract][Full Text] [Related]
55. Adverse effects of atypical antipsychotics : differential risk and clinical implications.
Haddad PM; Sharma SG
CNS Drugs; 2007; 21(11):911-36. PubMed ID: 17927296
[TBL] [Abstract][Full Text] [Related]
56. Are there any news about the antipsychotic medications in the elderly?
Cucinotta D; Minardi M; Lanfranchi G; Reggiani A; Savorani G
Arch Gerontol Geriatr; 2007; 44 Suppl 1():133-7. PubMed ID: 17317446
[TBL] [Abstract][Full Text] [Related]
57. Clinical effectiveness of new generation antipsychotics in adolescent patients.
Arango C; Parellada M; Moreno DM
Eur Neuropsychopharmacol; 2004 Nov; 14 Suppl 4():S471-9. PubMed ID: 15572266
[TBL] [Abstract][Full Text] [Related]
58. Second-generation antipsychotic medications in children and adolescents.
Cheng-Shannon J; McGough JJ; Pataki C; McCracken JT
J Child Adolesc Psychopharmacol; 2004; 14(3):372-94. PubMed ID: 15650494
[TBL] [Abstract][Full Text] [Related]
59. Paediatric atypical antipsychotic monitoring safety (PAMS) study: pilot study in children and adolescents in secondary- and tertiary-care settings.
Rani FA; Byrne PJ; Murray ML; Carter P; Wong IC
Drug Saf; 2009; 32(4):325-33. PubMed ID: 19388723
[TBL] [Abstract][Full Text] [Related]
60. [Prevention and treatment of somatic complications arising from the use of antipsychotics].
Cahn W; Ramlal D; Bruggeman R; de Haan L; Scheepers FE; van Soest MM; Assies J; Slooff CJ
Tijdschr Psychiatr; 2008; 50(9):579-91. PubMed ID: 18785105
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
